Abnormally phosphorylated tau is a common denominator in several types of dementia, including Alzheimer’s disease (AD) and other tauopathies (Goedert et al., 2010; Beharry et al., 2014). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.